Tijori
Jenburkt Pharmaceuticals Ltd.
Market Capital
₹ 192 Cr.
P/E
12.04
Share Price
₹ 426.30 (%)
  • Jenburkt Pharmaceuticals Ltd.
  • Overview
  • Connections
  • Financials
  • Benchmarking
  • Shareholding
  • Knowledge Base
  • Pharma Sector

  • Revenue Mix
  • Operational Metrics

  • Competitors

  • Price
  • Benchmarking
  • Growth Table
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results

  • Overview
  • Trend
  • Detailed

  • Recent News
  • Annual Reports

Revenue Mix
Product Break-Up
Location Wise Break-Up
Operational Metrics for Jenburkt Pharma
0.04% (as of Mar 19)
Change in PAT with 1% Appreciation in FX Basket
1.84% (as of Mar 19)
Management Compensation as a % of Sales
Pharmaceuticals
0.78% (as of Mar 20)
R&D as a % of Total Sales
Compare with Competitors


Competitors
Peer Name Market Cap.
Jenburkt Pharma Limited 192
Lincoln Pharmaceuticals Limited 466
TTK Healthcare Limited 803
Gufic Biosciences Limited 948
Morepen Laboratories Limited 1,311
Amrutanjan Health Care Limited 1,541
Novartis India Ltd 1,668
Indoco Remedies Limited 2,976
FDC Limited 5,548
Wockhardt Limited 5,924
JB Chemicals & Pharmaceuticals Limited 7,713
Eris Lifesciences 8,571
Glenmark Pharmaceuticals Limited 14,358
Ajanta Pharma Limited 15,370
Sanofi India Limited 19,138
Alembic Pharmaceuticals Limited 19,258
Pfizer Limited 22,553
GlaxoSmithKline Pharmaceuticals Limited 26,630
IPCA Laboratories Limited 26,692
Abbott India Limited 30,607
Alkem Laboratories Limited 36,867
Torrent Pharmaceuticals Limited 46,069
Lupin Limited 49,317
Cadila Healthcare Limited 49,749
Biocon Limited 53,964
Cipla Limited 67,146
Dr. Reddy's Laboratories Limited 84,457
Sun Pharmaceuticals Industries Limited 142,628
Show More
Financial
2764
Business
Price
426.30 (%)
Benchmarking
The Benchmarking section has been moved to the next tab. Please click
here


Growth Table
(in Rs. Cr.) 1yr 2yr 3yr 4yr 5yr 6yr 7yr 8yr 9yr 10yr
View more
View less
* Share price growth is updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Cash Flow
  • Standalone
  • Consolidated
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Ratios
  • Standalone
  • Consolidated
= Dominant Factor
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Quarterly Results
  • Standalone
  • Consolidated
(in Rs. Cr.) Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
View previous years
View fewer years
Overview
Shareholder Break-up
Trend
  • 1y
  • 2y
  • 4y
  • 5y
  • 10y
    Promoter
    Mutual Funds
    Insurance Companies
    FII
    DII Others
    Others